SuperworthStryker profit margin SYK
Gross, operating and net profit as a share of revenue over the last twelve months, from 2009.
- Net margin, 12 months
- 14.4%
- Operating margin, 12 months
- 21.4%
- Net margin on a year earlier
- +2.2 pts
- Peer median
- 14.7%
Over the twelve months to Jun 30, 2026, Stryker kept 14.4% of its revenue as net profit, with an operating margin of 21.4% and a gross margin of 65.0%.
Five years earlier its net margin was 12.8%.
The median for 7 medical device stocks of a similar size is 14.7%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 12.9% | 19.5% | 64.0% |
| FY2024 | 13.2% | 16.3% | 63.9% |
| FY2023 | 15.4% | 19.0% | 63.7% |
| FY2022 | 12.8% | 15.4% | 62.8% |
| FY2021 | 11.7% | 15.1% | 64.1% |
| FY2020 | 11.1% | 15.5% | 63.1% |
| FY2019 | 14.0% | 18.2% | 65.1% |
| FY2018 | 26.1% | 18.7% | 65.7% |
| FY2017 | 8.2% | 18.5% | 65.7% |
| FY2016 | 14.5% | 19.1% | 66.2% |
| FY2015 | 14.5% | 18.7% | 66.4% |
| FY2014 | 5.3% | 12.9% | 65.7% |
| FY2013 | 11.2% | 13.9% | 67.0% |
| FY2012 | 15.0% | 20.1% | 67.9% |
| FY2011 | 16.2% | 20.3% | 66.2% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 14.4% | +2.2 pts | 21.4% | |
| Q1 FY26 | 13.2% | +0.9 pts | 19.7% | |
| Q4 FY25 | 12.9% | −0.3 pts | 19.5% | |
| Q3 FY25 | 12.1% | −4.3 pts | 15.0% | |
| Q2 FY25 | 12.3% | −3.9 pts | 15.2% | |
| Q1 FY25 | 12.3% | −3.7 pts | 15.3% | |
| Q4 FY24 | 13.2% | −2.2 pts | 16.3% | |
| Q3 FY24 | 16.3% | +3.3 pts | 19.9% | |
| Q2 FY24 | 16.1% | +2.2 pts | 19.7% | |
| Q1 FY24 | 16.0% | +2.2 pts | 19.7% | |
| Q4 FY23 | 15.4% | +2.7 pts | 19.0% | |
| Q3 FY23 | 13.0% | −0.7 pts | 17.3% |
Against its peers
Companies in Medical - Devices nearest Stryker's size, closest first, today.
| Company | Profit margin |
|---|---|
| SYKStryker | 14.4% |
| MDTMedtronic | 13.9% |
| ABTAbbott Laboratories | n/m |
| BSXBoston Scientific | 17.5% |
| EWEdwards Lifesciences | 15.4% |
| GEHCGE HealthCare Technologies | 9.3% |
| DXCMDexCom | 20.1% |
| ZBHZimmer Biomet | 9.5% |
| Peer median | 14.7% |
Where Stryker ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Stryker
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.